Journal of Alzheimer's Disease xx (20xx) Abstract. The diagnosis of Alzheimer's disease (AD) is a critical step in the management of patients. We have developed a non-invasive diagnosis tool based on magnetic resonance molecular imaging (MRMI) of amyloid-␤ peptide using ultra-small particles of iron oxide (USPIO) functionalized with a disulfide constrained cyclic heptapeptide (PHO) identified by phage display (USPIO-PHO). After previously demonstrating the optimal pharmacologic properties of USPIO-PHO and its capacity to cross the blood-brain barrier (BBB), the ability of USPIO-PHO to target amyloid plaques (AP) by MRMI has been validated in the present work on AD transgenic mice. The immunohistochemistry and immunofluorescent detection of USPIO-PHO on brain sections collected after in vivo MRMI studies enabled its colocalization with AP, confirming the BBB passage and specific targeting. The AP targeting by USPIO-PHO has been moreover corroborated by the good correlation between the number of AP detected with anti-amyloid beta antibody and Perls'-DAB staining. Finally, the crossing mechanism of USPIO-PHO through the BBB was elucidated, revealing the involvement of non-degradation pathway of caveolae, while the control contrast agent USPIO-PEG was not endocytosed by the human brain endothelial cells. 
Keywords: Alzheimer's disease, amyloid-␤ peptide, blood-brain barrier, contrast agents, functionalized iron oxide nanoparticles, magnetic resonance imaging were injected with USPIO-PHO, while USPIO-PEG 236 was administered to three mice.
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The CAs were injected in the tail vein at a dose of Figure 1) . The results
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were expressed as percentage of black pixels in 285 post-contrast compared to pre-contrast images. tive control. Figure 1A shows the global darkening 
442
The same in vivo MRI experiment has been repro-443 duced on APTS mice which were supposed to exhibit 444 A␤ and neurofibrillary tangle pathology similar to those observed in AD patients by 6 months of age.
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The Supplementary Figure 2A aggregates.
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The strong and extended negative contrast Moreover, the thalamus delivery is facilitated by the 537 larger diameter of the blood vessels at this level as 538 compared to those in the cortex.
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To increase the access to the brain of USPIO-
540
PHO, a second study by MRI was performed using ative contrast produced by USPIO-PHO in the brain Figure 3) . bodies of neurons (Fig. 6, Supplementary Figure 5) . be detected within the lumen of these blood vessels (USPIO-PHO-rho) was colocalized with caveolae 674 and lysosomes in ACBRI376 human brain microvas-675 cular cells (Fig. 9) ; USPIO-PEG-rho was used as thus the microphotograph shown in Fig. 9B is 
h after administration (Supplementary

Conclusions
701
The development of diagnostic tools for AD is an 702 essential step toward a better management of patients from the very first stages of the cognitive decline. 
